Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: Accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera

Glycoconjugate Journal

Volumn 28, Issue 3-4, 2011, Pages 165-182

  Cox, Andrew D ^a   St Michael, Frank ^a   Cairns, Chantelle M ^a   Lacelle, Suzanne ^a   Filion, Amy Lea ^a   Neelamegan, Dhamodharan ^a   Wenzel, Cory Q ^a   Horan, Heather ^a   Richards, James C ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

Conjugate vaccine; Core oligosaccharide; LPS; Monoclonal antibody; Moraxella catarrhalis

Indexed keywords

AMIDASE; BACTERIAL VACCINE; BACTERIUM LIPOPOLYSACCHARIDE; CARBOXYL GROUP; CARRIER PROTEIN; EPITOPE; FATTY ACID; GLYCOCONJUGATE; LIPID A; MALEIMIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MC2 1; MONOCLONAL ANTIBODY MC2 10; MORAXELLA CATARRHALIS VACCINE; N ACETYLGLUCOSAMINE; OLIGOSACCHARIDE; THIOL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME ACTIVITY; LGT2 GENE; LGT4 GENE; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SEROTYPE; STRUCTURE ANALYSIS; VACCINE PRODUCTION; WHOLE CELL; WILD TYPE;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CARBOHYDRATE SEQUENCE; GLYCOCONJUGATES; LIPOPOLYSACCHARIDES; MICE; MOLECULAR SEQUENCE DATA; MORAXELLA (BRANHAMELLA) CATARRHALIS; OLIGOSACCHARIDES; RABBITS;

DICTYOSTELIUM DISCOIDEUM; MORAXELLA CATARRHALIS; MURINAE; MUS; ORYCTOLAGUS CUNICULUS;

EID: 79959768682     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-011-9332-7     Document Type: Article

References (38)

1. R Karalus AA Campagnari 2000 Moraxella catarrhalis: a review of an important human mucosal pathogen Microbes Infect. 2 547 559 10865200 10.1016/S1286-4579(00)00314-2 1:STN:280:DC%2BD3czisFOnsQ%3D%3D (Pubitemid 30387209)
2. TF Murphy 2005 Vaccine development for non-typable Haemophilus influenzae and Moraxella catarrhalis: progress and challenges Expert Rev. Vaccin. 4 843 853 10.1586/14760584.4.6.843 1:CAS:528:DC%2BD28Xpt1Cgtw%3D%3D (Pubitemid 43040905)
3. TF Murphy AL Brauer BJ Grant S Sethi 2005 Moraxella catarrhalis in chronic obstructive pulmonary disease. Burden of disease and immune response Am. J. Respir. Crit. Care Med. 172 195 199 15805178 10.1164/rccm.200412-1747OC (Pubitemid 40981193)
4. DI Brixner 2005 Improving acute otitis media outcomes through proper antibiotic use and adherence Am. J. Manag. Care 11 S202 S210 16111443
5. F Mawas MM Ho MJ Corbel 2009 Current progress with Moraxella catarrhalis as vaccine antigens Expert Rev. Vaccin. 8 77 90 10.1586/14760584.8.1.77 1:CAS:528:DC%2BD1cXhsFWjt7nK
6. H Masoud MB Perry J-R Brisson D Uhrin JC Richards 1994 Structural elucidation of the backbone oligosaccharide from the lipopolysaccharide of Moraxella catarrhalis serotype A Can. J. Chem. 72 1466 1477 10.1139/v94-182 1:CAS:528:DyaK2cXmtVGrt74%3D
7. P Edebrink P-E Jansson G Widmalm T Holme M Rahman 1996 The structures of oligosaccharides isolated from the lipopolysaccharide of Moraxella catarrhalis serotype B, strain CCUG 3292 Carbohydr. Res. 295 127 146 9002189 1:CAS:528:DyaK2sXltFOmtA%3D%3D (Pubitemid 26420114)
8. P Edebrink P-E Jansson MM Rahman G Widmalm T Holme M Rahman 1995 Structural studies on the O-antigen oligosaccharides from two strains of Moraxella catarrhalis serotype C Carbohydr. Res. 266 237 261 7535189 10.1016/0008-6215(94)00276-L 1:CAS:528:DyaK2MXjt1Snsb8%3D
9. JS Plested K Makepeace MP Jennings MA Gidney S Lacelle J-R Brisson AD Cox A Martin RG Bird CM Tang F Mackinnon JC Richards ER Moxon 1999 Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis Infect. Immun. 67 5417 5426 10496924 1:CAS:528:DyaK1MXmsFWmsrY%3D (Pubitemid 29455320)
10. AD Cox W Zou MAJ Gidney S Lacelle JS Plested K Makepeace JC Wright P Coull ER Moxon JC Richards 2005 Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunisation of mice and rabbits Vaccine 23 5045 5054 16046037 10.1016/j.vaccine.2005.06.011 1:CAS:528:DC%2BD2MXhtVehsrvO (Pubitemid 41318152)
11. SM Logan W Chen A Aubry MAJ Gidney S Lacelle F St. Michael R Kuolee M Higgins S Neufeld AD Cox 2006 Production of a D-glycero-D-manno- heptosyltransferase mutant of Mannheimia haemolytica displaying a veterinary pathogen specific conserved LPS structure and development and cross-reactivity of antibodies to this LPS structure Vet. Microbiol. 116 175 186 16750602 10.1016/j.vetmic.2006.04.024 1:CAS:528:DC%2BD28XnsFyntbo%3D (Pubitemid 44108508)
12. IR Peak ID Grice I Faglin Z Klipic PM Collins L van Schendel PG Hitchen HR Morris A Dell JC Wilson 2007 Towards understanding the functional role of the glycosyltransferases involved in the biosynthesis of Moraxella catarrhalis lipooligosaccharide FEBS J. 274 2024 2037 17388814 10.1111/j.1742-4658.2007. 05746.x 1:CAS:528:DC%2BD2sXltVeju7k%3D (Pubitemid 46588001)
13. XX Gu J Chen SJ Barenkamp JB Robbins C-M Tsai DJ Lim J Battey 1998 Synthesis and characterization of lipopolysaccharide based conjugates as vaccine candidates for Moraxella catarrhalis Infect. Immun. 66 1891 1897 9573066 1:CAS:528:DyaK1cXivFKqs7w%3D (Pubitemid 28194079)
14. W-G Hu J Chen JF Battey XX Gu 2000 Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipopolysaccharide from Moraxella catarrhalis conjugated to proteins Infect. Immun. 68 4980 4985 10948114 10.1128/IAI.68.9.4980-4985.2000 1:CAS:528:DC%2BD3cXmtVelu7c%3D
15. X Jiao T Hirano Y Hou XX Gu 2002 Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipopolysaccharide conjugate vaccine Infect. Immun. 70 5982 5989 12379673 10.1128/IAI.70.11.5982-5989.2002 1:CAS:528:DC%2BD38XotFGks78%3D (Pubitemid 35192686)
16. W-G Hu J Berry J Chen XX Gu 2004 Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipopolysaccharide- based conjugates FEMS Immunol. Med. Microbiol. 41 109 115 15145454 10.1016/j.femsim.2004.02.001 1:CAS:528:DC%2BD2cXktVOnu70%3D (Pubitemid 38625712)
17. S Yu XX Gu 2005 Synthesis and characterization of lipopolysaccharide- based conjugate vaccines for serotype B Moraxella catarrhalis Infect. Immun. 73 2790 2796 15845482 10.1128/IAI.73.5.2790-2796.2005 1:CAS:528: DC%2BD2MXjvV2isrw%3D (Pubitemid 40570345)
18. S Yu XX Gu 2007 Biological and immunological characteristics of lipopolysaccharide-based conjugate vaccines for serotype C Moraxella catarrhalis Infect. Immun. 75 2974 2980 17371852 10.1128/IAI.01915-06 1:CAS:528: DC%2BD2sXmtlKmsLc%3D (Pubitemid 46870180)
19. S Yu H Xie A Datta N Naidu XX Gu 2008 Galactose residues on the lipopolysaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination Infect. Immun. 76 4251 4258 18559429 10.1128/IAI.01570-07 1:CAS:528:DC%2BD1cXhtVyrsbzJ
20. O Westphal K Jann 1965 Bacterial lipopolysaccharide Methods Carbohydr. Chem. 5 88 91
21. DG Sawardeker JH Sloneker A Jeanes 1965 Quantitative determination of monosaccharides as their alditol acetates by gas liquid chromatography Anal. Chem. 37 1602 1604 10.1021/ac60231a048 1:CAS:528:DyaF28Xkslequw%3D%3D
22. I Ciucanu F Kerek 1994 A simple and rapid method for the permethylation of carbohydrates Carbohydr. Res. 131 209 217 10.1016/0008-6215(84)85242-8
23. AD Cox J Li J-R Brisson ER Moxon JC Richards 2002 Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide Carbohydr. Res. 337 1435 1444 12204604 10.1016/S0008-6215(02) 00161-1 1:CAS:528:DC%2BD38XmsFWhurw%3D (Pubitemid 35245430)
24. K Furano AA Campagnari 2003 Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera Infect. Immun. 71 1843 1848 12654799 10.1128/IAI.71.4.1843-1848.2003 1:CAS:528:DC%2BD3sXislOhs7k%3D (Pubitemid 36368714)
25. E Juni 1977 Genetic transformation assays for identification of strains of Moraxella urethralis J. Clin. Microbiol. 5 227 235 845247 1:STN:280:DyaE2s7ktFahsQ%3D%3D (Pubitemid 8052727)
26. M Claviez K Pagh H Maruta W Baltes P Fisher G Gerisch 1982 Electron microscopic mapping of monoclonal antibodies on the tail region of Dictyostelium myosin EMBO J. 1 1017 1022 16453425 1:STN:280:DC%2BC3crptFWgtg%3D%3D
27. UK Laemmli 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 680 685 5432063 10.1038/227680a0 1:CAS:528:DC%2BD3MXlsFags7s%3D
28. JM Schwingel KJ Edwards AD Cox H Masoud JC Richards F St. Michael CD Tekwe S Sethi TF Murphy AA Campagnari 2009 The use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies Infect. Immun. 77 4548 4558 19651870 10.1128/IAI.00294-09 1:CAS:528:DC%2BD1MXht1Ghu7jI
29. K Oishi H Tanaka F Sonoda S Borann K Ahmed Y Utsonomiya K Watanabe T Nagatake M Vaneechoutte G Verschraegen K Matsumoto 1996 A monoclonal antibody reactive with a common epitope of Moraxella (Branhamella) catarrhalis lipopolysaccharide Clin. Diagn. Lab. Immunol. 3 351 354 8705682 1:CAS:528:DyaK28XjslCktb8%3D (Pubitemid 26189639)
30. M Rahman A-B Jonsson T Holme 1998 Monoclonal antibodies to the epitope α-Gal-(1-4)-β-Gal-(1- of Moraxella catarrhalis LPS react with a similar epitope in type IV pili of Neisseria meningitidis Microb. Pathog. 24 299 308 9600862 10.1006/mpat.1997.0191 1:CAS:528:DyaK1cXjvFKjsbs%3D (Pubitemid 28266813)
31. W-G Hu J Chen JC McMichael XX Gu 2001 Functional characteristics of a protective monoclonal antibody against serotype A and C lipooligosaccharides from Moraxella catarrhalis Infect. Immun. 69 1358 1363 11179299 10.1128/IAI.69.3.1358-1363.2001 1:CAS:528:DC%2BD3MXitFGrtro%3D (Pubitemid 32187581)
32. AD Cox F StMichael D Neelamegan S Lacelle CM Cairns JC Richards 2010 Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading Glycoconj. J. 27 401 417 20340043 10.1007/s10719-010-9287-0 1:CAS:528:DC%2BC3cXmsVSmtrY%3D
33. A Bartoloni F Norelli C Ceccarini R Rappuoli P Costantino 1995 Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide Vaccine 13 463 470 7543714 10.1016/0264-410X(94)00007-A 1:CAS:528:DyaK2MXmtFajur4%3D
34. JM Peeters TG Hazendonk EC Beuvery GI Tesser 1989 Comparison of four bifunctional reagents for coupling peptides to proteins and the effect of the three moieties on the immunogenicity of the conjugates J. Immunol. Methods 120 133 143 2499636 10.1016/0022-1759(89)90298-6 1:CAS:528:DyaL1MXlslajs7k%3D (Pubitemid 19144205)
35. V Verez-Bencomo V Fernández-Santana E Hardy ME Toledo MC Rodríguez L Heynngnezz, et al. 2004 A synthetic conjugate polysaccharide vaccine against Haemophilus influenzae type B Science 305 522 525 15273395 10.1126/science.1095209 1:CAS:528:DC%2BD2cXlvVOktbc%3D (Pubitemid 38971343)
36. G Torano ME Toledo A Baly V Fernandez-Santana F Rodriguez Y Alvarez, et al. 2006 Phase I clinical evaluation of a synthetic oligosaccharide-protein conjugate vaccine against Haemophilus influenzae type B in human adult volunteers Clin. Vaccine Immunol. 13 1052 1056 16960118 10.1128/CVI.00144-06 1:CAS:528:DC%2BD28XhtVWgt7rI (Pubitemid 44518975)
37. A Fomsgaard MA Freudenberg C Galanos 2000 Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels J. Clin. Microbiol. 28 2627 2631
38. Ren, D.; Yu, S.; Gao, S.; Peng, D.; Petralia, R.S.; Muszynski, A.; Carlson, R.W.; Robbins, J.B.; Tsai, C.-M.; Lim, D.J.; and Gu, X.-X. Mutant lipooligosaccharide-based glycoconjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis. Vaccine (2011). doi: 10.1016/j.vaccine.2011.03.102